Blood markers for immune lung disease in children
Part of Lungs & breathing clinical trials.
This study looks at two blood markers (IL-6 and MMP-7) in children with immune-related lung disease to see if these markers can help doctors understand how serious the disease is and predict how it will progress. The goal is to help guide better treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 2 and 18 years old
- Your child has been diagnosed with an immune-related lung disease (such as lupus, arthritis, dermatomyositis, scleroderma, vasculitis, or sarcoidosis)
- Your child's diagnosis has been confirmed by a doctor using standard diagnostic criteria
- Blood samples can be safely collected and tested from your child to measure the two markers
- Your child does not have lung disease caused by infection, environmental exposure, medication, or injury
- Your child does not have other chronic lung problems like congenital lung abnormalities or cystic fibrosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at two substances in saliva and lung fluid—called IL-6 and TNF-α—in children with severe lung failure (ARDS) who are on a breathing machine. Measuring these markers may help doctors better understand the condition and guide treatment.
This study helps doctors identify early signs of lung scarring (fibrosis) in patients with autoimmune diseases like scleroderma, rheumatoid arthritis, and Sjögren's syndrome. By catching this early, researchers hope to better understand and treat these complications.
This study looks at how immune cells work in lung cancer and chronic lung diseases. It aims to find better ways to treat these conditions by studying immune cells from blood, bone marrow, or lung samples.
This study explores how the immune system and lung microbes affect children with lung disease. It uses extra fluid collected during a standard lung exam to look for new treatment targets.
This study collects health information and may store blood or other samples to learn more about interstitial lung disease (ILD) and autoimmune-related conditions. Joining could help researchers understand different causes of ILD and improve future care.
This registry collects health and breathing test information from adults with autoimmune-related lung scarring (interstitial lung disease) diagnosed recently. It helps researchers better understand who has this condition and how it changes over time.
Hear when a new Pediatric Immune Mediated Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.